News

As a leader in multiplex diagnostics at the Point of Care, QuantuMDx is committed to sharing ideas and being actively engaged to turn challenges into opportunities. Access here our news, blogs and events.

people hugging
People hugging

QuantuMDx awarded Outstanding Achievement Award at Medilink Healthcare Business Awards 2024

Read More

Transforming Point-of-Care Molecular Diagnostics at GIS23 Summit

Read More

QuantuMDx presents at The Union World Conference on Lung Health 2023

Read More

QuantuMDx receives CTDA approval for sale of Q-POC™

Read More

QuantuMDx & Menarini Announce Exclusive Distribution Agreement

Read More

QuantuMDx & Sansure Biotech Enters into Agreement

Read More

QuantuMDx announces webinar: Rising to the challenge

Read More

QuantuMDx Shortlisted for SelectScience Clinical Scientists Awards

Read More

Elaine Warburton OBE Wins InspiringFifty Europe 2022 Award

Read More

QuantuMDx Special Recognition at the 2022 Med-Tech Innovation Awards

Read More

QuantuMDx launches New PCR Respiratory Panel 

Read More

QuantuMDx wins MediLink Award 2022

Read More

QuantuMDx wins two Bionow Awards 2021

Read More

QuantuMDx Wins Made in North East Medical Life Sciences Award 2022

Read More

SARS-CoV-2 RT-PCR Detection Assay receives CTDA legislation approval

Read More

Martin Walton appointed as Chief Financial Officer

Read More

Q-POC™ SARS-CoV-2 assay receives CTDA legislation approval

Read More

QuantuMDx confirm its tests detect all known COVID-19 variants

Read More

QuantuMDx investment from Vita Spring and future cooperation plans

Read More

QuantuMDx partners with Cignpost Diagnostics

Read More

QuantuMDx launches Q-POC™ – a PCR diagnostic system

Read More

QuantuMDx included on PHE Microbiology Framework

Read More

Mirre de Noo appointed as non-executive director

Read More

QuantuMDx completes £11m funding round

Read More

Prime Minister, Boris Johnson visits QuantuMDx

Read More